← Return to (MAC/MAI) Mycobacterium Avium Complex Pulmonary Disease: Join us

Discussion
Comment receiving replies
Replies to "Hi all, more good news on Bronchiectasis today https://bronchiectasisnewstoday.com/2017/09/26/fda-accepts-aradigms-nda-for-linhaliq-to-treat-non-cystic-fibrosis-bronchiectasis/?utm_source=BRO+E-mail+List&utm_campaign=33eecc16ae-RSS_WEEKLY_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_d9df0e1c03-33eecc16ae-72406537"

@heathert Wow! That is great news! They are two months ahead of schedule for filing the application. Aradigm was one of the sponsors at the NTM conference in D.C. They said they planned on filing that app in Dec. & were trying to get it released by spring of 2018. Lets hope that early filing will mean an early release. I am impressed, because the speaker said they would try to expedite that.

Oh so groovy!!